Overview
Status
Active
Registry date
2012-05-25
Share capital
50,000.00 PLN
Registered address
ul. Wołoska 16, 02-675 Warszawa, Poland
Electronic delivery address
AE:PL-25921-29775-DTEII-24
Financials
Revenue history (in k)
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 117 days for 2022), 1 not filed. 3 of 5 audited by a statutory auditor.
- 202526/06/2026
- 2024not filed
- 202328/10/2024
- 202209/11/2023
- 202103/11/2022
- 202025/11/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Voivodeship · Mazowieckie119,202 / 142,033
Top 84%
Country · Poland424,534 / 495,860
Top 86%
Results vs industry
Revenue
This companyUSD 5.06kMedianUSD 287.80kAverageUSD 4.91m
Net profit
This companyUSD -13.35kMedianUSD 12.59kAverageUSD 208.04k
Operating costs
This companyUSD 18.41kMedianUSD 272.78kAverageUSD 4.49m
Assets
This companyUSD 282.08kMedianUSD 224.38kAverageUSD 5.76m
Industry
Authorized Representatives
Hermann Josef Müller Menrad – President of the Management Board
Manner of representation
Each member of the management board acting independently is authorized to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ferdinand Menrad Holding-gmbh | 1,000 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2012-05-16.
32 1090 1043 0000 0001 6432 3028
Debt
2 active proceedings recorded in KRZ.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Oct 16, 2025 | Bankruptcy proceedings for an entrepreneur | In progress | |
| Aug 27, 2025 | Petition to declare entrepreneur bankruptcy | Closed |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 3, 2020 | Other crisis aid | $13,127$13,127 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Poldentsp. z o.o. | $9,440,759.21 | poldent.pl | ||
| Metzer Medizin- Und Industrietechniksp. z o.o. | $1,511,723.18 | metzer.pl | ||
| Endotradesp. z o.o. | $912,862.33 | endotrade.pl | ||
| Your Labsp. z o.o. | $198,230.62 | yourlab.pl | ||
| PhilabsS.A. | $64,403.10 | phibox.eu | ||
| IDL Polandsp. z o.o. | $43,351.03 | idlpoland.com | ||
| Milton EssexS.A. | $40,863.48 | miltonessex.eu | ||
| NEO Ortho Pracownia Sztuki Ortopedycznejsp. z o.o. | $5,662.74 | neoortho.pl | ||
| Bioimplantisp. z o.o. | $1,660.39 | bioimplanti.pl | ||
| Royal Methodsp. z o.o. | $1,089.26 | royal-method.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-12-29 | Name change (Menard Polska Spółka Z Ograniczoną Odpowiedzialnością W Upadłości → Menrad Polska Spółka Z Ograniczoną Odpowiedzialnością W Upadłości) | |
| 2025-10-27 | Name change (Menrad Polska → Menard Polska Spółka Z Ograniczoną Odpowiedzialnością W Upadłości) | |
| 2021-10-13 | Address change (Transportowców 11, 02-858, Warszawa → Ul. Wołoska 16, 02-675, Warszawa) | |
| 2021-04-01 | PKD change (Removed: 13, 73, 74; Added: 32.50.Z) | |
| 2012-10-10 | Address change (Hrubieszowska 2, 01-209, Warszawa → Transportowców 11, 02-858, Warszawa) |
FAQ
The main business activity of Menrad Polska focuses on manufacture of medical and dental instruments and supplies.
The company was registered in the Polish National Court Register (KRS) on May 25, 2012.
The headquarters is located at: ul. Wołoska 16, 02-675 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
In 2023, the company generated total revenue of $1,567,588, representing an increase of 13.3% compared to 2022.
Yes, in 2023 the company achieved a net profit of $105,989.
The largest operating cost category falls under external services. This category amounted to $441,707 in 2023, representing 31% of all operating expenses.
Last updated: 2026-10-07